Drug Patents owned by Neos Theraps Inc

1. Drug name - ADZENYS ER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9017731 NEOS THERAPS INC Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles Jun, 2032

(9 years from now)

US9265737 NEOS THERAPS INC Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles Jun, 2032

(9 years from now)

US8709491 NEOS THERAPS INC Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles Jun, 2032

(9 years from now)

Drugs and Companies using AMPHETAMINE ingredient

Treatment: NA

Dosage: SUSPENSION, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 1.25MG BASE/ML SUSPENSION, EXTENDED RELEASE;ORAL Discontinued

2. Drug name - COTEMPLA XR-ODT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8840924 NEOS THERAPS INC Compositions and methods of making rapidly dissolving ionically masked formulations Jun, 2026

(3 years from now)

US9089496 NEOS THERAPS INC Compositions comprising methylphenidate complexed with ion-exchange resin particles Jun, 2032

(9 years from now)

US9072680 NEOS THERAPS INC Compositions comprising methylphenidate complexed with ion-exchange resin particles Jun, 2032

(9 years from now)

US11166947 NEOS THERAPS INC Effective dosing of a child for the treatment of ADHD with methylphenidate Jan, 2038

(15 years from now)

Drugs and Companies using METHYLPHENIDATE ingredient

Treatment: Treatment of attention deficit hyperactivity disorder (adhd) in pediatric patients

Dosage: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
8.6MG TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL Prescription
17.3MG TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL Prescription
25.9MG TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.